Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis
Gavin Giovannoni(Queen Mary University of London), Edward J. Thompson(National Hospital for Neurology and Neurosurgery), N. A. Losseff, Michael Sailer(University of Augsburg), David H. Miller(National Hospital for Neurology and Neurosurgery), Alan J. Thompson(Queen Mary University of London), N. Lewellyn-Smith(University of London)
Cited by 86
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k